BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fraguas-Sánchez AI, Torres-Suárez AI. Medical Use of Cannabinoids. Drugs 2018;78:1665-703. [PMID: 30374797 DOI: 10.1007/s40265-018-0996-1] [Cited by in Crossref: 108] [Cited by in F6Publishing: 81] [Article Influence: 27.0] [Reference Citation Analysis]
Number Citing Articles
1 Rivas-Santisteban R, Lillo J, Raïch I, Muñoz A, Lillo A, Rodríguez-Pérez AI, Labandeira-García JL, Navarro G, Franco R. The cannabinoid CB(1) receptor interacts with the angiotensin AT(2) receptor. Overexpression of AT(2)-CB(1) receptor heteromers in the striatum of 6-hydroxydopamine hemilesioned rats. Exp Neurol 2023;362:114319. [PMID: 36632949 DOI: 10.1016/j.expneurol.2023.114319] [Reference Citation Analysis]
2 Fernández-Moncada I, Marsicano G. Astroglial CB1 receptors, energy metabolism, and gliotransmission: an integrated signaling system? Essays Biochem 2023;67:49-61. [PMID: 36645029 DOI: 10.1042/EBC20220089] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Alswailmi FK. A Cross Talk between the Endocannabinoid System and Different Systems Involved in the Pathogenesis of Hypertensive Retinopathy. Pharmaceuticals 2023;16:345. [DOI: 10.3390/ph16030345] [Reference Citation Analysis]
4 Sánchez-Sánchez L, García J, Fernández R, Noskova E, Egiguren-Ortiz J, Gulak M, Ochoa E, Laso A, Oiarbide M, Santos JI, Fe Andrés M, González-Coloma A, Adell A, Astigarraga E, Barreda-Gómez G. Characterization of the Antitumor Potential of Extracts of Cannabis sativa Strains with High CBD Content in Human Neuroblastoma. Int J Mol Sci 2023;24. [PMID: 36835247 DOI: 10.3390/ijms24043837] [Reference Citation Analysis]
5 Hasbi A, Madras BK, George SR. Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review. Brain Sci 2023;13. [PMID: 36831868 DOI: 10.3390/brainsci13020325] [Reference Citation Analysis]
6 Pennant NM, Hinton CV. The evolution of cannabinoid receptors in cancer. WIREs Mech Dis 2023;:e1602. [PMID: 36750231 DOI: 10.1002/wsbm.1602] [Reference Citation Analysis]
7 Martini S, Gemma A, Ferrari M, Cosentino M, Marino F. Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance. Int J Mol Sci 2023;24. [PMID: 36834537 DOI: 10.3390/ijms24043125] [Reference Citation Analysis]
8 Rezende B, Alencar AKN, de Bem GF, Fontes-dantas FL, Montes GC. Endocannabinoid System: Chemical Characteristics and Biological Activity. Pharmaceuticals 2023;16:148. [DOI: 10.3390/ph16020148] [Reference Citation Analysis]
9 Bobitt J, Clary K, Krawitz M, Silva LQ, Kang H. Prevention, Practice, and Policy: Older US Veterans' Perspectives on Cannabis Use. Drugs Aging 2023;40:59-70. [PMID: 36648751 DOI: 10.1007/s40266-022-00995-2] [Reference Citation Analysis]
10 Hajirahimkhan S, Hefferon K, Jackowetz N. The Functional Compounds of Cannabis sativa. Reference Module in Food Science 2023. [DOI: 10.1016/b978-0-12-823960-5.00044-5] [Reference Citation Analysis]
11 Oshaghi M, Kourosh-Arami M, Roozbehkia M. Role of neurotransmitters in immune-mediated inflammatory disorders: a crosstalk between the nervous and immune systems. Neurol Sci 2023;44:99-113. [PMID: 36169755 DOI: 10.1007/s10072-022-06413-0] [Reference Citation Analysis]
12 Bagüés A, Benítez D, Abalo R. Cannabinoids to Fight Chemotherapy-Induced Adverse Effects. Handbook of Cancer and Immunology 2023. [DOI: 10.1007/978-3-030-80962-1_350-1] [Reference Citation Analysis]
13 Fraguas-sánchez AI, Torres-suárez AI. Therapeutic uses of Cannabis sativa L. Current state and future perspectives. Current Applications, Approaches, and Potential Perspectives for Hemp 2023. [DOI: 10.1016/b978-0-323-89867-6.00010-x] [Reference Citation Analysis]
14 Gómez-Cañas M, Morales P, Satta V, Rodríguez-Cueto C, García C, Sagredo O. Editorial: Cannabinoids as potential treatment for neurological diseases. Front Neurosci 2022;16:1108101. [PMID: 36605545 DOI: 10.3389/fnins.2022.1108101] [Reference Citation Analysis]
15 Er A, Celik S. The Uses of Cannabinoids in Medicine and Their Spectroscopic Applications. Medical Cannabis and the Effects of Cannabinoids on Fighting Cancer, Multiple Sclerosis, Epilepsy, Parkinson's, and Other Neurodegenerative Diseases 2022. [DOI: 10.4018/978-1-6684-5652-1.ch010] [Reference Citation Analysis]
16 Galant N, Czarny J, Powierska-Czarny J, Piotrowska-Cyplik A. Development and Validation of the LC-MS/MS Method for Determination of 130 Natural and Synthetic Cannabinoids in Cannabis Oil. Molecules 2022;27. [PMID: 36500694 DOI: 10.3390/molecules27238601] [Reference Citation Analysis]
17 Lei S, Chen X, Wu J, Duan X, Men K. Small molecules in the treatment of COVID-19. Signal Transduct Target Ther 2022;7:387. [PMID: 36464706 DOI: 10.1038/s41392-022-01249-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Eichorn NL, Shult HT, Kracht KD, Berlau DJ. Making a joint decision: Cannabis as a potential substitute for opioids in obstetrics and gynecology. Best Pract Res Clin Obstet Gynaecol 2022;85:59-67. [PMID: 35970747 DOI: 10.1016/j.bpobgyn.2022.07.002] [Reference Citation Analysis]
19 Reddy VA, Leong SH, Jang IC, Rajani S. Metabolic Engineering of Nicotiana benthamiana to Produce Cannabinoid Precursors and Their Analogues. Metabolites 2022;12. [PMID: 36557219 DOI: 10.3390/metabo12121181] [Reference Citation Analysis]
20 Worster B, Hajjar ER, Handley N. Cannabis Use in Patients With Cancer: A Clinical Review. JCO Oncol Pract 2022;18:743-9. [PMID: 35749680 DOI: 10.1200/OP.22.00080] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Maioli C, Mattoteia D, Amin HIM, Minassi A, Caprioglio D. Cannabinol: History, Syntheses, and Biological Profile of the Greatest “Minor” Cannabinoid. Plants 2022;11:2896. [DOI: 10.3390/plants11212896] [Reference Citation Analysis]
22 Moreno-Sanz G, Madiedo A, Lynskey M, Brown MRD. "Flower Power": Controlled Inhalation of THC-Predominant Cannabis Flos Improves Health-Related Quality of Life and Symptoms of Chronic Pain and Anxiety in Eligible UK Patients. Biomedicines 2022;10. [PMID: 36289837 DOI: 10.3390/biomedicines10102576] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Edinoff AN, Wu NW, Nix CA, Bonin B, Mouhaffel R, Vining S, Gibson W, Cornett EM, Murnane KS, Kaye AM, Kaye AD. Historical Pathways for Opioid Addiction, Withdrawal with Traditional and Alternative Treatment Options with Ketamine, Cannabinoids, and Noribogaine: A Narrative Review. Health Psychol Res 2022;10:38672. [PMID: 36628122 DOI: 10.52965/001c.38672] [Reference Citation Analysis]
24 Saleemi MA, Yahaya N, Zain NNM, Raoov M, Yong YK, Noor NS, Lim V. Antimicrobial and Cytotoxic Effects of Cannabinoids: An Updated Review with Future Perspectives and Current Challenges. Pharmaceuticals (Basel) 2022;15:1228. [PMID: 36297340 DOI: 10.3390/ph15101228] [Reference Citation Analysis]
25 Stasiulewicz A, Lesniak A, Setny P, Bujalska-Zadrożny M, Sulkowska JI. Identification of CB1 Ligands among Drugs, Phytochemicals and Natural-Like Compounds: Virtual Screening and In Vitro Verification. ACS Chem Neurosci 2022;13:2991-3007. [PMID: 36197801 DOI: 10.1021/acschemneuro.2c00502] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Santos WBDR, Guimarães JO, Pina LTS, Serafini MR, Guimarães AG. Antinociceptive effect of plant-based natural products in chemotherapy-induced peripheral neuropathies: A systematic review. Front Pharmacol 2022;13:1001276. [DOI: 10.3389/fphar.2022.1001276] [Reference Citation Analysis]
27 Gómez-garcía DM, García-perdomo HA. Cannabis medicinal: puntos críticos para su uso clínico. biomedica 2022;42:450-459. [DOI: 10.7705/biomedica.6468] [Reference Citation Analysis]
28 Ott S, Herrmann-werner A, Zipfel S, Schlisio B. SOP Dronabinol und andere Cannabinoide in der Schmerztherapie. PSYCH up2date 2022;16:371-377. [DOI: 10.1055/a-1770-3935] [Reference Citation Analysis]
29 Caprioglio D, Amin HIM, Taglialatela-Scafati O, Muñoz E, Appendino G. Minor Phytocannabinoids: A Misleading Name but a Promising Opportunity for Biomedical Research. Biomolecules 2022;12:1084. [PMID: 36008978 DOI: 10.3390/biom12081084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Walsh KB, Holmes AE. Pharmacology of Minor Cannabinoids at the Cannabinoid CB1 Receptor: Isomer- and Ligand-Dependent Antagonism by Tetrahydrocannabivarin. Receptors 2022;1:3-12. [DOI: 10.3390/receptors1010002] [Reference Citation Analysis]
31 Leo LM, Al-zoubi R, Hurst DP, Stephan AP, Zhao P, Tilley DG, Miess E, Schulz S, Abood ME, Reggio PH. The NPXXY Motif Regulates β-Arrestin Recruitment by the CB1 Cannabinoid Receptor. Cannabis and Cannabinoid Research. [DOI: 10.1089/can.2021.0223] [Reference Citation Analysis]
32 Melzer R, Mccabe PF, Schilling S. Evolution, genetics and biochemistry of plant cannabinoid synthesis: a challenge for biotechnology in the years ahead. Current Opinion in Biotechnology 2022;75:102684. [DOI: 10.1016/j.copbio.2022.102684] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
33 Delussi M, Sciruicchio V, Paolo T, Morgante F, Salvatore E, Ferrara IP, Clemente L, Sorbera C, de Tommaso M. Lower Prevalence of Chronic Pain in Manifest Huntington’s Disease: A Pilot Observational Study. Brain Sciences 2022;12:676. [DOI: 10.3390/brainsci12050676] [Reference Citation Analysis]
34 Lacroix C, Alleman-Brimault I, Zalta A, Rouby F, Cassé-Perrot C, Jouve E, Attolini L, Guilhaumou R, Micallef J, Blin O. What Do We Know About Medical Cannabis in Neurological Disorders and What Are the Next Steps? Front Pharmacol 2022;13:883987. [PMID: 35571129 DOI: 10.3389/fphar.2022.883987] [Reference Citation Analysis]
35 Srivastava RK, Lutz B, Ruiz de Azua I. The Microbiome and Gut Endocannabinoid System in the Regulation of Stress Responses and Metabolism. Front Cell Neurosci 2022;16:867267. [DOI: 10.3389/fncel.2022.867267] [Reference Citation Analysis]
36 Mohamed S, Lopane G, Sabattini L, Scandellari C, Zardi D, Donadio V, Rizzo G, Perrone A, Lugaresi A, Contin M. Cannabis-Based Products in a Neurological Setting: A Clinical and Pharmacokinetic Survey. Front Neurol 2022;13:784748. [PMID: 35418935 DOI: 10.3389/fneur.2022.784748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Carreira LD, Matias FC, Campos MG. Clinical Data on Canabinoids: Translational Research in the Treatment of Autism Spectrum Disorders. Biomedicines 2022;10:796. [DOI: 10.3390/biomedicines10040796] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Hatziagapiou K, Bethanis K, Koniari E, Christoforides E, Nikola O, Andreou A, Mantzou A, Chrousos GP, Kanaka-gantenbein C, Lambrou GI. Biophysical Studies and In Vitro Effects of Tumor Cell Lines of Cannabidiol and Its Cyclodextrin Inclusion Complexes. Pharmaceutics 2022;14:706. [DOI: 10.3390/pharmaceutics14040706] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
39 Pagano C, Navarra G, Coppola L, Avilia G, Bifulco M, Laezza C. Cannabinoids: Therapeutic Use in Clinical Practice. IJMS 2022;23:3344. [DOI: 10.3390/ijms23063344] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
40 Tampa M, Neagu M, Caruntu C, Georgescu SR. Personalized Medicine in the Field of Inflammatory Skin Disorders. JPM 2022;12:426. [DOI: 10.3390/jpm12030426] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Sionov RV, Steinberg D. Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles. Biomedicines 2022;10:631. [DOI: 10.3390/biomedicines10030631] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
42 Khan H, Ghori FK, Ghani U, Javed A, Zahid S. Cannabinoid and endocannabinoid system: a promising therapeutic intervention for multiple sclerosis. Mol Biol Rep 2022. [PMID: 35182322 DOI: 10.1007/s11033-022-07223-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Bajtel Á, Kiss T, Tóth B, Kiss S, Hegyi P, Vörhendi N, Csupor-Löffler B, Gede N, Hohmann J, Csupor D. The Safety of Dronabinol and Nabilone: A Systematic Review and Meta-Analysis of Clinical Trials. Pharmaceuticals (Basel) 2022;15:100. [PMID: 35056154 DOI: 10.3390/ph15010100] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Hryhorowicz S, Kaczmarek-Ryś M, Zielińska A, Scott RJ, Słomski R, Pławski A. Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease - A Systematic Review. Front Immunol 2021;12:790803. [PMID: 35003109 DOI: 10.3389/fimmu.2021.790803] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
45 Atkins M, López IG, Kuo B. Nausea and Vomiting. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00182-1] [Reference Citation Analysis]
46 Pinto JS, Martel F. Effects of Cannabidiol on Appetite and Body Weight: A Systematic Review. Clin Drug Investig 2022;42:909-19. [PMID: 36180814 DOI: 10.1007/s40261-022-01205-y] [Reference Citation Analysis]
47 Idris AI. Role of classical cannabinoid receptors in cancer-associated bone disease. Bone Cancer 2022. [DOI: 10.1016/b978-0-12-821666-8.00049-9] [Reference Citation Analysis]
48 Slawek DE, Curtis SA, Arnsten JH, Cunningham CO. Clinical Approaches to Cannabis: A Narrative Review. Med Clin North Am 2022;106:131-52. [PMID: 34823727 DOI: 10.1016/j.mcna.2021.08.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
49 Almeida CF, Teixeira N, Correia-da-Silva G, Amaral C. Cannabinoids in Breast Cancer: Differential Susceptibility According to Subtype. Molecules 2021;27:156. [PMID: 35011388 DOI: 10.3390/molecules27010156] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
50 Gökgöz A, Yilmaz Can E. Medikal ve Endüstriyel Açıdan Kannabinoidlerin Önemi ve Türkiye Ekonomisine Katkı Potansiyeli. Medical Journal of Western Black Sea 2021;5:315-323. [DOI: 10.29058/mjwbs.928899] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Walsh KB, McKinney AE, Holmes AE. Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses. Front Pharmacol 2021;12:777804. [PMID: 34916950 DOI: 10.3389/fphar.2021.777804] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
52 Cong J, Lu K, Zou W, Li Z, Guo Z, Tong X, Zheng J, Zhu J, Li S, Zhang W, Guo Y, Gao TM, Chen R. Astroglial CB1 Cannabinoid Receptors Mediate CP 55,940-Induced Conditioned Place Aversion Through Cyclooxygenase-2 Signaling in Mice. Front Cell Neurosci 2021;15:772549. [PMID: 34887729 DOI: 10.3389/fncel.2021.772549] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
53 Almeida MM, Dias-Rocha CP, Calviño C, Trevenzoli IH. Lipid endocannabinoids in energy metabolism, stress and developmental programming. Mol Cell Endocrinol 2021;542:111522. [PMID: 34843899 DOI: 10.1016/j.mce.2021.111522] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Ma L, Wu S, Zhang K, Tian M, Zhang H. Progress on the application of positron emission tomography imaging of cannabinoid type 1 receptor in neuropsychiatric diseases. Zhejiang Da Xue Xue Bao Yi Xue Ban 2021;50:666-73. [PMID: 34986538 DOI: 10.3724/zdxbyxb-2021-0063] [Reference Citation Analysis]
55 Huff HC, Vasan A, Roy P, Kaul A, Tajkhorshid E, Das A. Differential Interactions of Selected Phytocannabinoids with Human CYP2D6 Polymorphisms. Biochemistry 2021;60:2749-60. [PMID: 34491040 DOI: 10.1021/acs.biochem.1c00158] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
56 Pereira GC, Prates G, Medina M, Ferreira C, Latorraca COC, Pacheco RL, Martimbianco ALC, Riera R. High frequency of spin bias in controlled trials of cannabis derivatives and their synthetic analogues: A meta-epidemiologic study. J Clin Epidemiol 2021;140:3-12. [PMID: 34450305 DOI: 10.1016/j.jclinepi.2021.08.024] [Reference Citation Analysis]
57 Singh K, Nassar N, Bachari A, Schanknecht E, Telukutla S, Zomer R, Piva TJ, Mantri N. The Pathophysiology and the Therapeutic Potential of Cannabinoids in Prostate Cancer. Cancers (Basel) 2021;13:4107. [PMID: 34439262 DOI: 10.3390/cancers13164107] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
58 Leonardo Tibiriçá C, Juliana Weckx PM, Beatriz do Prado PF, Jeferson S, Leandro Yanase R, Estherlopes R, Lorena DPP, Leonardo Ribeiro DP, Guilherme Mendes R, Vinicius Barroso H, André Rinaldi F. Cannabinoids as a yield modifier in physical activit: A systematic review characters. J Sports Med Ther 2021;6:018-021. [DOI: 10.29328/journal.jsmt.1001053] [Reference Citation Analysis]
59 Lin YF. Potassium channels as molecular targets of endocannabinoids. Channels (Austin) 2021;15:408-23. [PMID: 34282702 DOI: 10.1080/19336950.2021.1910461] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
60 Marzęda P, Drozd M, Wróblewska-Łuczka P, Łuszczki JJ. Cannabinoids and their derivatives in struggle against melanoma. Pharmacol Rep 2021. [PMID: 34264513 DOI: 10.1007/s43440-021-00308-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Topuz RD, Cetinkaya MZ, Erumit D, Duvan Aydemir K, Gunduz O, Karadag CH, Ulugol A. The role of endocannabinoid system and TRPV1 receptors in the antidepressant and anxiolytic effects of dipyrone in chronic unpredictable mild stress in mice. Eur J Pharmacol 2021;908:174315. [PMID: 34270988 DOI: 10.1016/j.ejphar.2021.174315] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Murillo-Rodríguez E, Millán-Aldaco D, Arankowsky-Sandoval G, Yamamoto T, Pertwee RG, Parker L, Mechoulam R. Assessing the treatment of cannabidiolic acid methyl ester: a stable synthetic analogue of cannabidiolic acid on c-Fos and NeuN expression in the hypothalamus of rats. J Cannabis Res 2021;3:31. [PMID: 34253253 DOI: 10.1186/s42238-021-00081-1] [Reference Citation Analysis]
63 Orjuela-Rojas JM, García Orjuela X, Ocampo Serna S. Medicinal cannabis: knowledge, beliefs, and attitudes of Colombian psychiatrists. J Cannabis Res 2021;3:26. [PMID: 34225825 DOI: 10.1186/s42238-021-00083-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
64 Schilling S, Dowling CA, Shi J, Ryan L, Hunt DJL, O'reilly E, Perry AS, Kinnane O, Mccabe PF, Melzer R. The Cream of the Crop: Biology, Breeding, and Applications of Cannabis Sativa. Annual Plant Reviews online 2021. [DOI: 10.1002/9781119312994.apr0740] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
65 Badria FA, Elgazar AA. Immunomodulatory Activity of Cannabinoids: From Abuse to Therapy. Phytopharmaceuticals 2021. [DOI: 10.1002/9781119682059.ch17] [Reference Citation Analysis]
66 Stairs J, Maguire F, Lehmann C, Cox A. Cannabinoid Therapy in Female Pelvic Medicine and Reconstructive Surgery: Current Evidence and Future Directions. Curr Bladder Dysfunct Rep 2021;16:64-73. [DOI: 10.1007/s11884-021-00632-5] [Reference Citation Analysis]
67 Topal L, Naveed M, Orvos P, Pászti B, Prorok J, Bajtel Á, Kiss T, Csupor-Löffler B, Csupor D, Baczkó I, Varró A, Virág L, Jost N. The electrophysiological effects of cannabidiol on action potentials and transmembrane potassium currents in rabbit and dog cardiac ventricular preparations. Arch Toxicol 2021;95:2497-505. [PMID: 34031697 DOI: 10.1007/s00204-021-03086-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Methaneethorn J, Poomsaidorn C, Naosang K, Kaewworasut P, Lohitnavy M. A Δ9-Tetrahydrocannabinol Physiologically-Based Pharmacokinetic Model Development in Humans. Eur J Drug Metab Pharmacokinet 2020;45:495-511. [PMID: 32266676 DOI: 10.1007/s13318-020-00617-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
69 Dunn M, Mirda D, Whalen MJ, Kogan M. An integrative active surveillance of prostate cancer. Explore (NY) 2021:S1550-8307(21)00083-5. [PMID: 33980424 DOI: 10.1016/j.explore.2021.04.005] [Reference Citation Analysis]
70 Moreno E, Cavic M, Canela EI. Functional Fine-Tuning of Metabolic Pathways by the Endocannabinoid System-Implications for Health and Disease. Int J Mol Sci 2021;22:3661. [PMID: 33915889 DOI: 10.3390/ijms22073661] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
71 Amaral C, Trouille FM, Almeida CF, Correia-da-Silva G, Teixeira N. Unveiling the mechanism of action behind the anti-cancer properties of cannabinoids in ER+ breast cancer cells: Impact on aromatase and steroid receptors. J Steroid Biochem Mol Biol 2021;210:105876. [PMID: 33722705 DOI: 10.1016/j.jsbmb.2021.105876] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
72 Copeland-Halperin LR, Herrera-Gomez LC, LaPier JR, Shank N, Shin JH. The Effects of Cannabis: Implications for the Surgical Patient. Plast Reconstr Surg Glob Open 2021;9:e3448. [PMID: 33747688 DOI: 10.1097/GOX.0000000000003448] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
73 Contin M, Mohamed S, Santucci M, Lodi MAM, Russo E, Mecarelli O, Cbd Lice Italy Study Group. Cannabidiol in Pharmacoresistant Epilepsy: Clinical Pharmacokinetic Data From an Expanded Access Program. Front Pharmacol 2021;12:637801. [PMID: 33746760 DOI: 10.3389/fphar.2021.637801] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
74 Velayudhan L, McGoohan K, Bhattacharyya S. Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis. PLoS Med 2021;18:e1003524. [PMID: 33780450 DOI: 10.1371/journal.pmed.1003524] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 10.5] [Reference Citation Analysis]
75 Breijyeh Z, Jubeh B, Bufo SA, Karaman R, Scrano L. Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses. Toxins (Basel) 2021;13:117. [PMID: 33562446 DOI: 10.3390/toxins13020117] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
76 Scarante FF, Ribeiro MA, Almeida-Santos AF, Guimarães FS, Campos AC. Glial Cells and Their Contribution to the Mechanisms of Action of Cannabidiol in Neuropsychiatric Disorders. Front Pharmacol 2020;11:618065. [PMID: 33613284 DOI: 10.3389/fphar.2020.618065] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
77 Wang S, Li B, Shen X, Duan H, Guo Z, Li X, Sun F. The cannabinoid receptor CB1 affects the proliferation and apoptosis of adenomyotic human uterine smooth muscle cells of the junctional zone: a mechanism study. Reprod Biol Endocrinol 2021;19:16. [PMID: 33531043 DOI: 10.1186/s12958-020-00690-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
78 Velayudhan L, McGoohan KL, Bhattacharyya S. Evaluation of THC-Related Neuropsychiatric Symptoms Among Adults Aged 50 Years and Older: A Systematic Review and Metaregression Analysis. JAMA Netw Open 2021;4:e2035913. [PMID: 33528550 DOI: 10.1001/jamanetworkopen.2020.35913] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
79 Arias S, Leon M, Jaimes D, Bustos RH. Clinical Evidence of Magistral Preparations Based on Medicinal Cannabis. Pharmaceuticals (Basel) 2021;14:78. [PMID: 33494156 DOI: 10.3390/ph14020078] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
80 Pérez-Olives C, Rivas-Santisteban R, Lillo J, Navarro G, Franco R. Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer's, Parkinson's, and Huntington's Diseases. Adv Exp Med Biol 2021;1264:81-92. [PMID: 33332005 DOI: 10.1007/978-3-030-57369-0_6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
81 Arboleda MF, Prosk E. Practical Recommendations for the Use of Medical Cannabis. Cannabinoids and Pain 2021. [DOI: 10.1007/978-3-030-69186-8_21] [Reference Citation Analysis]
82 Rock EM, Parker LA. Constituents of Cannabis Sativa. Adv Exp Med Biol 2021;1264:1-13. [PMID: 33332000 DOI: 10.1007/978-3-030-57369-0_1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
83 Chung M, Benkli B, Hirani S, Le-short C. Cannabinoids and Cancer Pain. Cannabinoids and Pain 2021. [DOI: 10.1007/978-3-030-69186-8_26] [Reference Citation Analysis]
84 Wallach J. Medicinal Cannabis: an overview for health-care providers. Remington 2021. [DOI: 10.1016/b978-0-12-820007-0.00005-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
85 Petrescu NB, Jurj A, Sorițău O, Lucaciu OP, Dirzu N, Raduly L, Berindan-Neagoe I, Cenariu M, Boșca BA, Campian RS, Ilea A. Cannabidiol and Vitamin D3 Impact on Osteogenic Differentiation of Human Dental Mesenchymal Stem Cells. Medicina (Kaunas) 2020;56:E607. [PMID: 33198232 DOI: 10.3390/medicina56110607] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
86 Moreno E, Cavic M, Krivokuca A, Canela EI. The Interplay between Cancer Biology and the Endocannabinoid System-Significance for Cancer Risk, Prognosis and Response to Treatment. Cancers (Basel) 2020;12:E3275. [PMID: 33167409 DOI: 10.3390/cancers12113275] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
87 Taylor C, Birch B. Cannabinoids in Urology. Which Benign Conditions Might They Be Appropriate to Treat: A Systematic Review. Urology 2021;148:8-25. [PMID: 33129871 DOI: 10.1016/j.urology.2020.10.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
88 Moore CF, Stiltner JW, Davis CM, Weerts EM. Translational models of cannabinoid vapor exposure in laboratory animals. Behav Pharmacol 2020. [PMID: 33136615 DOI: 10.1097/FBP.0000000000000592] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
89 Ma C, Zhang M, Liu L, Zhang P, Liu D, Zheng X, Zhong X, Wang G. Low-dose cannabinoid receptor 2 agonist induces microglial activation in a cancer pain-morphine tolerance rat model. Life Sci 2021;264:118635. [PMID: 33131746 DOI: 10.1016/j.lfs.2020.118635] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
90 Pizzol D, Demurtas J, Stubbs B, Soysal P, Mason C, Isik AT, Solmi M, Smith L, Veronese N. Relationship Between Cannabis Use and Erectile Dysfunction: A Systematic Review and Meta-Analysis. Am J Mens Health 2019;13:1557988319892464. [PMID: 31795801 DOI: 10.1177/1557988319892464] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
91 Mostafavi M, Gaitanis J. Autism Spectrum Disorder and Medical Cannabis: Review and Clinical Experience. Semin Pediatr Neurol 2020;35:100833. [PMID: 32892960 DOI: 10.1016/j.spen.2020.100833] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
92 Orvos P, Pászti B, Topal L, Gazdag P, Prorok J, Polyák A, Kiss T, Tóth-Molnár E, Csupor-Löffler B, Bajtel Á, Varró A, Hohmann J, Virág L, Csupor D. The electrophysiological effect of cannabidiol on hERG current and in guinea-pig and rabbit cardiac preparations. Sci Rep 2020;10:16079. [PMID: 32999428 DOI: 10.1038/s41598-020-73165-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
93 Mahabir VK, Merchant JJ, Smith C, Garibaldi A. Medical cannabis use in the United States: a retrospective database study. J Cannabis Res 2020;2:32. [PMID: 33526110 DOI: 10.1186/s42238-020-00038-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
94 Fraguas-Sánchez AI, Fernández-Carballido A, Martin-Sabroso C, Torres-Suárez AI. Stability characteristics of cannabidiol for the design of pharmacological, biochemical and pharmaceutical studies. J Chromatogr B Analyt Technol Biomed Life Sci 2020;1150:122188. [PMID: 32506012 DOI: 10.1016/j.jchromb.2020.122188] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
95 Tomko AM, Whynot EG, Ellis LD, Dupré DJ. Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis. Cancers (Basel) 2020;12:E1985. [PMID: 32708138 DOI: 10.3390/cancers12071985] [Cited by in Crossref: 44] [Cited by in F6Publishing: 51] [Article Influence: 14.7] [Reference Citation Analysis]
96 Martínez-Pinilla E, Rico AJ, Rivas-Santisteban R, Lillo J, Roda E, Navarro G, Lanciego JL, Franco R. Expression of GPR55 and either cannabinoid CB1 or CB2 heteroreceptor complexes in the caudate, putamen, and accumbens nuclei of control, parkinsonian, and dyskinetic non-human primates. Brain Struct Funct 2020;225:2153-64. [PMID: 32691218 DOI: 10.1007/s00429-020-02116-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
97 Fraguas-Sánchez AI, Fernández-Carballido A, Delie F, Cohen M, Martin-Sabroso C, Mezzanzanica D, Figini M, Satta A, Torres-Suárez AI. Enhancing ovarian cancer conventional chemotherapy through the combination with cannabidiol loaded microparticles. Eur J Pharm Biopharm 2020;154:246-58. [PMID: 32682943 DOI: 10.1016/j.ejpb.2020.07.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
98 Klahn P. Cannabinoids-Promising Antimicrobial Drugs orIntoxicants with Benefits? Antibiotics (Basel) 2020;9:E297. [PMID: 32498408 DOI: 10.3390/antibiotics9060297] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
99 Brunetti P, Pichini S, Pacifici R, Busardò FP, Del Rio A. Herbal Preparations of Medical Cannabis: A Vademecum for Prescribing Doctors. Medicina (Kaunas) 2020;56:E237. [PMID: 32429074 DOI: 10.3390/medicina56050237] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 10.3] [Reference Citation Analysis]
100 Fraguas-Sánchez AI, Torres-Suárez AI, Cohen M, Delie F, Bastida-Ruiz D, Yart L, Martin-Sabroso C, Fernández-Carballido A. PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment. Pharmaceutics 2020;12:E439. [PMID: 32397428 DOI: 10.3390/pharmaceutics12050439] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 5.7] [Reference Citation Analysis]
101 Heaney LM. Advancements in mass spectrometry as a tool for clinical analysis: Part I. Clinical Chemistry and Laboratory Medicine (CCLM) 2020;58:639-42. [DOI: 10.1515/cclm-2020-0199] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
102 Alves P, Amaral C, Teixeira N, Correia-da-Silva G. Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol. Pharmacol Res 2020;157:104822. [PMID: 32335286 DOI: 10.1016/j.phrs.2020.104822] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 13.0] [Reference Citation Analysis]
103 Stasiulewicz A, Znajdek K, Grudzień M, Pawiński T, Sulkowska AJI. A Guide to Targeting the Endocannabinoid System in Drug Design. Int J Mol Sci 2020;21:E2778. [PMID: 32316328 DOI: 10.3390/ijms21082778] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 17.0] [Reference Citation Analysis]
104 Reddy V, Grogan D, Ahluwalia M, Salles ÉL, Ahluwalia P, Khodadadi H, Alverson K, Nguyen A, Raju SP, Gaur P, Braun M, Vale FL, Costigliola V, Dhandapani K, Baban B, Vaibhav K. Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies. EPMA J 2020;11:217-50. [PMID: 32549916 DOI: 10.1007/s13167-020-00203-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
105 Methaneethorn J, Naosang K, Kaewworasut P, Poomsaidorn C, Lohitnavy M. Development of a Physiologically-Based Pharmacokinetic Model of Δ9-Tetrahydrocannabinol in Mice, Rats, and Pigs. Eur J Drug Metab Pharmacokinet 2020;45:487-94. [DOI: 10.1007/s13318-020-00616-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
106 Pereira L, Núñez-Iglesias MJ, Domínguez-Martís EM, López-Ares D, González-Peteiro M, Novío S. Nursing Students' Knowledge and Attitudes Regarding Medical Marijuana: A Descriptive Cross-Sectional Study. Int J Environ Res Public Health 2020;17:E2492. [PMID: 32268474 DOI: 10.3390/ijerph17072492] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
107 Maayah ZH, Takahara S, Ferdaoussi M, Dyck JRB. The molecular mechanisms that underpin the biological benefits of full-spectrum cannabis extract in the treatment of neuropathic pain and inflammation. Biochim Biophys Acta Mol Basis Dis 2020;1866:165771. [PMID: 32201189 DOI: 10.1016/j.bbadis.2020.165771] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
108 Bouso JC, Jiménez-Garrido D, Ona G, Woźnica D, Dos Santos RG, Hallak JEC, Paranhos BAPB, de Almeida Mendes F, Yonamine M, Alcázar-Córcoles MÁ, Farré M. Quality of Life, Mental Health, Personality and Patterns of Use in Self-Medicated Cannabis Users with Chronic Diseases: A 12-Month Longitudinal Study. Phytother Res 2020;34:1670-7. [PMID: 32083789 DOI: 10.1002/ptr.6639] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
109 Murillo-rodríguez E, Arankowsky-sandoval G, Pertwee RG, Parker L, Mechoulam R. Sleep and neurochemical modulation by cannabidiolic acid methyl ester in rats. Brain Research Bulletin 2020;155:166-73. [DOI: 10.1016/j.brainresbull.2019.12.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
110 Duszak RS, Carr ER, Acharya RK, Stottlemyer LV. Drugs used in ocular treatment. Side Effects of Drugs Annual 2020. [DOI: 10.1016/bs.seda.2020.08.010] [Reference Citation Analysis]
111 Pearlson G. Medical marijuana and clinical trials. Weed Science 2020. [DOI: 10.1016/b978-0-12-818174-4.00010-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
112 Beubler E. Schmerztherapie mit Nicht-Analgetika. Kompendium der medikamentösen Schmerztherapie 2020. [DOI: 10.1007/978-3-662-60346-8_5] [Reference Citation Analysis]
113 Szok D, Tajti J, Nyári A, Vécsei L. Therapeutic Approaches for Peripheral and Central Neuropathic Pain. Behav Neurol 2019;2019:8685954. [PMID: 31871494 DOI: 10.1155/2019/8685954] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 10.0] [Reference Citation Analysis]
114 Brutman JN, Zhang S, Choi P, Zhang Y, Stotts MJ, Michal J, Jiang Z, Davis JF. Vapor Cannabis Exposure Promotes Genetic Plasticity in the Rat Hypothalamus. Sci Rep 2019;9:16866. [PMID: 31728018 DOI: 10.1038/s41598-019-53516-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
115 Deabold KA, Schwark WS, Wolf L, Wakshlag JJ. Single-Dose Pharmacokinetics and Preliminary Safety Assessment with Use of CBD-Rich Hemp Nutraceutical in Healthy Dogs and Cats. Animals (Basel) 2019;9:E832. [PMID: 31635105 DOI: 10.3390/ani9100832] [Cited by in Crossref: 47] [Cited by in F6Publishing: 52] [Article Influence: 11.8] [Reference Citation Analysis]
116 Sarzi-puttini P, Batticciotto A, Atzeni F, Bazzichi L, Di Franco M, Salaffi F, Marotto D, Ceribelli A, Ablin JN, Hauser W. Medical cannabis and cannabinoids in rheumatology: where are we now? Expert Review of Clinical Immunology 2019;15:1019-32. [DOI: 10.1080/1744666x.2019.1665997] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
117 Botsford SL, Yang S, George TP. Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential. Am J Addict 2020;29:9-26. [PMID: 31577377 DOI: 10.1111/ajad.12963] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
118 Oza M, Becker W, Gummadidala PM, Dias T, Omebeyinje MH, Chen L, Mitra C, Jesmin R, Chakraborty P, Sajish M, Hofseth LJ, Banerjee K, Wang Q, Moeller PDR, Nagarkatti M, Nagarkatti P, Chanda A. Acute and short-term administrations of delta-9-tetrahydrocannabinol modulate major gut metabolomic regulatory pathways in C57BL/6 mice. Sci Rep 2019;9:10520. [PMID: 31324830 DOI: 10.1038/s41598-019-46478-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
119 Kopruszinski CM, Navratilova E, Vagnerova B, Swiokla J, Patwardhan A, Dodick D, Porreca F. Cannabinoids induce latent sensitization in a preclinical model of medication overuse headache. Cephalalgia 2020;40:68-78. [PMID: 31311288 DOI: 10.1177/0333102419865252] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
120 Pélissier-alicot A, Manzoni O. Le THC : une vieille molécule, de nouvelles perspectives. Toxicologie Analytique et Clinique 2019;31:S46-S47. [DOI: 10.1016/j.toxac.2019.03.064] [Reference Citation Analysis]
121 Kerage D, Sloan EK, Mattarollo SR, McCombe PA. Interaction of neurotransmitters and neurochemicals with lymphocytes. J Neuroimmunol 2019;332:99-111. [PMID: 30999218 DOI: 10.1016/j.jneuroim.2019.04.006] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 9.8] [Reference Citation Analysis]
122 Martinez AE. Time to drop the stigma: cannabinoids are drugs that may alleviate pain in people with epidermolysis bullosa. Br J Dermatol 2019;180:711-2. [PMID: 30933348 DOI: 10.1111/bjd.17619] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
123 Shen X, Duan H, Wang S, Gan L, Xu Q, Li JJ. Decreased Expression of Cannabinoid Receptors in the Eutopic and Ectopic Endometrium of Patients with Adenomyosis. Biomed Res Int 2019;2019:5468954. [PMID: 30800671 DOI: 10.1155/2019/5468954] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
124 Lewis F, Lossignol D, Delvaux N, Hertay A, Razavi D. Prise en charge de la douleur. Psycho-Oncologie de L'adulte 2019. [DOI: 10.1016/b978-2-294-75811-9.00020-9] [Reference Citation Analysis]
125 Yonis E, Hussain I. Rules of prescribing: Prescribing cannabinoids – how relaxed are the rules? Br Dent J 2019;226:2-3. [DOI: 10.1038/sj.bdj.2019.14] [Reference Citation Analysis]
126 Alsherbiny MA, Li CG. Medicinal Cannabis-Potential Drug Interactions. Medicines (Basel) 2018;6:E3. [PMID: 30583596 DOI: 10.3390/medicines6010003] [Cited by in Crossref: 65] [Cited by in F6Publishing: 72] [Article Influence: 13.0] [Reference Citation Analysis]